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Studies on
the Mechanism of 1,3-Butadieninduced Leukemogenesis:
The Potential Role of Endogenous
Murine Leukemia Virus
by Richard D. Irons*
Previous studies have revealed marked differences in the incidence ofleukemia between rats and mice
exposed to 1,3-butadiene that do not appear to be readily explained on the basis of pharmacokinetics or
metabolism. Chronic exposure to 1,3-butadiene results in a high incidence ofthymic lymphoma inB6C3Fj
micethat is notobserved inSprague-Dawley rats. Studies attheChemical Industry Institute ofToxicology
have focused on evaluating the potential of endogenous ecotropic retroviral background to influence
susceptibility to 1,3-butadiene leukemogenesis. These studies have compared the pathogenesis and inci-
dence of thymic lymphoma between B6C3F1 and NIH Swiss mice. Proviral ecotropic sequences are
truncated in the NIH Swiss mouse, and the virus is notexpressed. Chronic exposure to 1,3-butadiene (1250
ppm)forupto 1yearresulted inafourfolddifference intheincidenceofthymiclymphomabetweenB6C3F1
andNIHSwiss mice. TheseresultsprovidepresumptiveevidenceforretrovirusinvolvementsinceNIHSwiss
micelackecotropic viruses andappeartoberelativelyresistanttoinductionoflymphomaby1,3-butadiene.
Otherexplanations appeartobelesslikely inlightofthefactthattargetorgantoxicityhasbeendetermined
to be virtually identical between the two strains during the preleukemic phase of1,3-butadiene exposure.
Introduction
One of the most intriguing aspects of 1,3-butadiene
toxicity is the marked species difference in its carcino-
genic potency-a central factor being the remarkably
high incidence of thymic leukemia/lymphoma en-
countered in B6C3F1 mice but not rats (1-2). The im-
portanceofelucidatingthemechanismsof1,3-butadiene
leukemogenesisinthemouseisunderscoredbyevidence
suggesting that there may be an increased risk oflym-
phatic and hematopoietic neoplasms in 1,3-butadiene-
exposed populations (3-6). Mechanisms most likely to
contribute to major species or strain differences in
chemically induced leukemogenesis are metabolism or
retroviral background. Quantitative differences in the
rates of 1,3-butadiene metabolism between rats and
mice have been described; however, it is unlikely these
canaccountfortheobserveddifferencesinsusceptibility
to 1,3-butadiene-leukemogenesis because comparable
tissue metabolite concentrations have been demon-
strated in both species over the range of 1,3-butadiene
exposure concentrations that were employed (7). Be-
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cause of the frequent association of endogenous retro-
virus with spontaneous lymphomas in the mouse, a
major focus of our studies has been to determine if
endogenous retroviral background could potentially in-
fluence 1,3-butadiene-leukemogenesis.
Endogenous Retroviruses and
Munne Leukemogenesis
Laboratory mice possess a number ofproviral genes
that code for retroviruses or retroviruslike elements
that have been collectively termed murine leukemia
viruses (MuLV). Without modification, endogenous
MuLVsequenceshavenotbeendirectlyassociatedwith
pathology(8). Allleukemogenic MuLV characterized to
date are recombinants, the formation of which has not
been observed in the absence of complete ecotropic
sequences (9-11). Therefore, it has been proposed that
leukemogenesis must be preceded by the generation of
recombinant virus sequences, and that both ecotropic
andrecombinantvirusesmayplaycriticalrolesinstrain-
specific viral liukemogenesis (12).
The role ofendogenous retrovirus in the etiology of
chemically induced murine leukemogenesis is presently
not understood. MuLV are known to produce a highR. D. IRONS
incidence of spontaneous leukemias in specific mouse
strains such asthe AKRand C58(10,13). Leukemogenic
retroviruses have been isolated from radiation-induced
leukemias in certain strainsincludingthe parent strains
ofthe B6C3F1 hybrid mouse (14-20), and there is evi-
dence that ecotropic and recombinant MuLV play
critical roles in strain-specific spontaneous leu-
kemogenesis (12). In spontaneous leukemias of the
mouse, theroleforMuLVisdefinitive(8); nevertheless,
contradictory findings have been encountered in chemi-
cal leukemogenesis in certain strains. A filterable leu-
kemogenic agent has been isolated from thymic lym-
phomas from CFW/D mice induced by 7,12-dimethyl-
benz[a]anthracene or3-methylcholanthrene(MCA)(21).
However, others have been unable to establish a viral
etiology in MCA-induced lymphomas in RF/J mice
(22,23).
Although the mechanisms of leukemogenesis are po-
tentially complex, the number of practical possibilities
involving ecotropic retrovirus can be reduced to a small
number. These alternative scenarios area)retroviruses
are generated that are leukemogenic; 1,3-butadiene is
not; b) both altered retroviruses and 1,3-butadiene ex-
posure are independently leukemogenic (additive co-
carcinogenesis); c) ecotropic retrovirus sequences are
necessary but not frankly leukemogenic by themselves
(facilitative co-carcinogenesis); d)ecotropicretroviruses
are activated but play no role in 1,3-butadiene-induced
leukemogenesis; and e) ecotropic retroviruses are not
activated and play no role in 1,3-butadiene-induced leu-
kemogenesis. These alternatives were initially evalu-
ated in a series ofcomparative studies using two differ-
entstrains ofmice, the B6C3F1 andthe NIH Swiss. The
B6C3F1 hybrid waschosenbecauseithasbeen shownto
develop a high incidence ofthymic lymphoma following
1,3-butadiene exposure. The NIH Swiss mouse was
chosen because it does not possess intact endogenous
ecotropic retrovirus sequences, does not express ec-
otropic retroviruses, and rarely expresses any type of
endogenous retrovirus (24,25).
Comparative Studies on the
Pathogenesis of 1,3-Butadiene-
induced Leukemia/Lymphoma
A predominant feature ofmost leukemias in man and
experimental animals is the involvement of the hema-
topoietic stem cell as a common target in the leu-
kemogenic process. Furthermore, bone marrow injury
plays an essential role in radiation-induced leukemia/
lymphoma(19,26,27). Therefore, itisnotsurprisingthat
the bone marrow is the primarytarget organfor 1,3-bu-
tadiene toxicity (28). Subehronic exposure of B6C3F1
mice to 1250 ppm for 3 to 24 weeks resulted in a macro-
cytic anemia with alterations reminiscent of those en-
counteredinmegaloblasicanemiainman. Thesechanges
were accompanied by alterations in bone marrow stem
cell proliferation and differentiation (29). In addition,
1,3-butadiene exposure resulted in amarkedincrease in
the number of micronuclei in bone marrow and the
peripheral circulation (Fig. 1) and increases in the fre-
quency of chromosomal aberrations of the chromatid
type in B6C3F1 mice (28,30). Since no extranumerary
chromosomes were noted, it was concluded that the
mechanism of micronuclei formation following 1,3-bu-
tadiene exposure is most likely due to chromatid breaks
rather than mitotic spindle events.
A striking finding was the increase in recoverable
ecotropicMuLVfrombonemarrow, thymus, andspleen
ofB6C3F1 mice (31). This was most pronounced in the
spleen and amounted to a 1 to 10 x 103 increase in the
FIGURE 1. Micronuclei inbone marrowcells fromB6C3F1, mouse exposed to 1,3-butadiene (1250ppm)for6weeks. (Bone marrow smear;Wright
stain; x630).
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FIGURE2. Ecotropicretrovirus expressioninspleensofB6C3F1 mice.
1,3-Butadiene-exposed (0); control(0);X-axis, durationofexposure;
Y-axis, infectious centers/106 cells. Trace: virus detectable but only
after multiple passages. 0: no virus detectable after multiple pas-
sages. Figure modified from Irons et al. (31).
production of ecotropic MuLV during the preleukemic
phase of 1,3-butadiene exposure (Fig. 2). Additional
experiments revealed that the mechanism of viral acti-
vation probably involves de novo increases in selective
ecotropic MuLV replication in individual cells, rather
thanalterations intheabilityofthemicetorestrictvirus
movement.
Exposure of NIH Swiss mice to 1,3-butadiene under
identical conditions resulted in a macrocytic anemia,
increases in circulating micronuclei, as well as micro-
nuclei and chromosomal abnormalities in bone marrow
cells (30,32). Ineachcasethechangeswerequalitatively
and quantitatively indistinguishable from those de-
scribed in 1,3-butadiene-exposed B6C3F1 mice. The
principle difference between the two strains was the
inability to recover MuLV of any type from tissues of
NIH Swiss mice (31). These findings are summarized in
Table 1.
Comparative Lymphoma/Leukemia
Incidence Study
The incidence of thymic lymphoma/leukemia in
B6C3F1 mice chronically exposed to 1250 ppm 1,3-buta-
diene for 1 year was 57% (33). This is nearly identical to
the 60% incidence previously reportedby Huffetal. (1).
These presented predominantly as mediastinal masses,
the thymus showing primary involvement in the major-
ity of cases (Fig. 3). A single lymphoid tumor was en-
countered inthe controlgroup. Inaddition, asignificant
incidence of thymic lymphoma (21%) was also en-
counteredinB6C3F1miceexposedfor12weeksandheld
for 1 year (Fig. 4). Thymic lymphoma were character-
ized asaggressive lymphoid tumors, consistingofhighly
proliferative uniform populations of well-differentiated
lymphoblasts, with frequent involvement of adjacent
anddistanttissuesincludinglungs, heart, spleen, lymph
nodes, liver, and kidney. Although the incidence of
thymiclymphoma washigherinanimals exposed forthe
full year, no differences in the latency or time-to-tumor
were noted between the two groups (Fig. 5). Cyto-
fluorometric analysis revealed the thymic lymphoma to
be of T-cell origin and to exhibit variable but elevated
surface expression of MuLV env antigens (Fig. 6). In
contrast, NIH Swiss mice exposed to 1,3-butadiene for
52 weeks presented with a much lower incidence of
thymic lymphoma (14%) (Fig. 7). These tumors were
morphologically similartothose encountered in B6C3F1
mice and expressed T-cell but no MuLV env surface
antigens.
Table 1. Comparative hematology of B6C3F1 and NIH Swiss mice following exposure to 1,3-butadiene.a
B6C3F1 NIH Swiss
Peripheral blood Treated Control (%A) Treated Control (%A)
White blood cells x 103 1.61 2.34 - 31* 1.60 2.13 - 25*
Hematocrit 36.9 43.3 - 15 32.5 40.0 - 21
Hemoglobin 12.8 14.9 - 14 11.4 13.8 - 17
Red blood cells x 106 RBC 6.55 8.9 - 26 5.95 7.93 - 25
Mean corpuscular volume 56.2 48.7 + 15 50.5 54.6 + 8
Reticulocytes/103 RBC 50.8 31.5 + 61* 46.7 50.6 + 8*
Micronuclei/103 RBC 26.5 5.0 + 530 26.4 3.4 + 776
Bone marrow cellularity x 106 19.7 21.9 - 10 19.3 26.2 - 26
Chromatid abberations 47 2 33 4
aU11 parameters measured after 6weeks ofexposure to 1250 ppm except chromatid aberrations which were measured 24 hr after asingle6-hr
exposure. Table is taken from Irons et al. (33).
*Difference not significant at p < 0.05.
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FIGURE 3. Photomicrograph ofthymiclymphomafrom 1,3-butadiene-
treated B6C3F1 mouse. Tumors consist of rapidly proliferating
well-differentiated blast cells. (H&E paraffin; x630).
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FIGURE 5. Chronology of thymic lymphomas in B6C3Fj mice chron-
ically exposed to 1,3-butadiene (11250 ppm) for (A) 12 or (B) 52
weeks. Figure taken from Irons et al. (33).
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FIGURE 4. Incidence of thymic lymphoma in B6C3F1 mice at 1 year
following exposure to 1,3-butadiene (1250 ppm) for 0, 12, or 52
weeks. Figure taken from Irons et al. (33).
Discussion
Understandingthemechanismofthymiclymphomain
1,3-butadiene-exposed mice is ofmajorimportance, es-
pecially when viewed in light of the possibility that
1,3-butadiene exposure in man may be associated with
an increased incidence of similar neoplasms. Although
the data are incompatible with the hypothesis that leu-
kemogenic MuLV are entirely responsible for the inci-
dence of thymic lymphoma, the described studies sug-
gestthatecotropicMuLVmayinfluencetheincidence of
1,3-butadiene-induced lymphomainthemouse. Amajor
difference between NIH SwissandB6C3F1miceistheir
respective ecotropic retroviral background, and the
prospect that differences in leukemiaincidence could be
explained by strain-specific metabolism orbioactivation
of1,3-butadiene remainsunlikely, since, withtheexcep-
tion of the increased recovery of ecotropic retrovirus
fromtissuesofB6C3F1 mice, targetorgantoxicityinthe
two strains is qualitatively and quantitatively identical
following 1,3-butadiene exposure. Therefore, ecotropic
retroviral background remains the most likely ex-
planation for the marked difference in lymphoma inci-
denceencounteredinthese micefollowing1,3-butadiene
exposure. It is possible that two additive mechanisms,
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FIGURE 6. Flow cytometric contourprojections ofnormalthymic (A) and respective leukemiacells (B) showingdualexpression ofMuLV envand
Thy 1.2 antigens. The leukemia shown exhibited the lowest amounts ofenv expression ofseven isolated and characterized. Figuretakenfrom
Irons et al. (33).
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FIGURE 7. Comparative incidence ofthymiclymphomainB6C3F1 and
NIH Swissmicechronicallyexposedto 1,3-butadiene (1250ppm)for
1 year. Taken from Irons et al. (33).
one requiring retrovirus and one not, account for the
increased incidence oflymphoma in the B6C3F1 mouse.
Alternatively, retrovirus may play a synergistic role in
1,3-butadiene-induced lymphoma. Transformation of
leukemia virus-infected rat or mouse embryo cells by
chemicals has been demonstrated under conditions
where neither virus infection nor chemical treatment
alone resulted in transformation (34-38).
Experiments that will be necessary to provide defini-
tive confirmation of the role of endogenous ecotropic
MuLV in 1,3-butadiene leukemogenesis in the mouse
include: determination ofthe leukemogenicity ofretro-
viral isolates from 1,3-butadiene-induced lymphomas
and a comparison of susceptibility to 1,3-butadiene-
leukemogenesis between congenic mouse strains differ-
ingonlyatthe ecotropicretrovirus locus. Moreover, the
mechanism of 1,3-butadiene-induced de novo activation
ofMuLVinmouse cells needs tobe exploredin orderto
determine the relevance of this model, if any, to the
potentialfor1,3-butadiene toaltertheexpression, repli-
cation, or latency ofretroviruses in other species. Evi-
dence strongly suggests that environmental or occu-
pational factors influence transformation in HTLV-
1-associated neoplasms in man (39), and chemical
alterations in HTLV-1 expression in human cells in
culture have been reported (40-42).
ItispossiblethattheB6C3F1hybridmaynotproveto
be the most appropriate animal model for extrapolation
ofthe risk of 1,3-butadiene leukemogenesis to the gen-
eral human population. Ifa definitive role for MuLV is
established, a strain that does not express ecotropic
MuLVmaybemoreappropriate. Independently, ifsimi-
larities exist between the effects of1,3-butadiene or its
metabolites on the expression ofretroviruses in mouse
and humancells, thenthe B6C3F1 mouse maybe appro-
priate for modeling at least one human population at
potential risk, e.g., human T-lymphotrophic virus
type-l-infected individuals. Furthermore, ifthe biology
ofhumanretroviruses isaltered following 1,3-butadiene
exposure, then other potential human health risks, in-
cluding but not limited to leukemia, need to be
evaluated.
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